These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29374532)

  • 41. [Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology].
    Shelkovnikova TA; Kulikova AA; Tsvetkov FO; Peters O; Bachurin SO; Bukhman VL; Ninkina NN
    Mol Biol (Mosk); 2012; 46(3):402-15. PubMed ID: 22888630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conformational evolution of polymorphic amyloid assemblies.
    Liang C; Hsieh MC; Li NX; Lynn DG
    Curr Opin Struct Biol; 2018 Aug; 51():135-140. PubMed ID: 29729574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
    Karatas E; Bouchecareilh M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autophagy Modulation as a Treatment of Amyloid Diseases.
    Mputhia Z; Hone E; Tripathi T; Sargeant T; Martins R; Bharadwaj P
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31527516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Misfolding of Proteins.
    Argyrou A
    Adv Exp Med Biol; 2020; 1195():249-254. PubMed ID: 32468483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amyloids as Building Blocks for Macroscopic Functional Materials: Designs, Applications and Challenges.
    Li J; Zhang F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Associative Memory, Water Mediated, Structure and Energy Model (AWSEM)-Amylometer: Predicting Amyloid Propensity and Fibril Topology Using an Optimized Folding Landscape Model.
    Chen M; Schafer NP; Zheng W; Wolynes PG
    ACS Chem Neurosci; 2018 May; 9(5):1027-1039. PubMed ID: 29241326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of Protein Amyloid-Like Aggregates by Solid-State Circular Dichroism Spectroscopy.
    Hu HY; Jiang LL; Hong JY
    Curr Protein Pept Sci; 2017; 18(1):100-103. PubMed ID: 27396751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanochaperone-Based Strategies to Control Protein Aggregation Linked to Conformational Diseases.
    Caballero AB; Gamez P
    Angew Chem Int Ed Engl; 2021 Jan; 60(1):41-52. PubMed ID: 32706460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Theoretical approaches to protein aggregation.
    Gsponer J; Vendruscolo M
    Protein Pept Lett; 2006; 13(3):287-93. PubMed ID: 16515457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amyloid protein aggregates: new clients for mitochondrial energy production in the brain?
    Sivanesan S; Chang E; Howell MD; Rajadas J
    FEBS J; 2020 Aug; 287(16):3386-3395. PubMed ID: 31981301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring the polymorphism, conformational dynamics and function of amyloidogenic peptides and proteins by temperature and pressure modulation.
    Ostermeier L; de Oliveira GAP; Dzwolak W; Silva JL; Winter R
    Biophys Chem; 2021 Jan; 268():106506. PubMed ID: 33221697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peptide Amyloids in the Origin of Life.
    Greenwald J; Kwiatkowski W; Riek R
    J Mol Biol; 2018 Oct; 430(20):3735-3750. PubMed ID: 29890117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The chaperonin CCT promotes the formation of fibrillar aggregates of γ-tubulin.
    Pouchucq L; Lobos-Ruiz P; Araya G; Valpuesta JM; Monasterio O
    Biochim Biophys Acta Proteins Proteom; 2018 Apr; 1866(4):519-526. PubMed ID: 29339327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
    Huang L; Liu X; Cheng B; Huang K
    Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyloids, amorphous aggregates and assemblies of peptides - Assessing aggregation.
    Juković M; Ratkaj I; Kalafatovic D; Bradshaw NJ
    Biophys Chem; 2024 May; 308():107202. PubMed ID: 38382283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
    Foguel D; Silva JL
    Biochemistry; 2004 Sep; 43(36):11361-70. PubMed ID: 15350123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gelsolin Amyloidogenesis Is Effectively Modulated by Curcumin and Emetine Conjugated PLGA Nanoparticles.
    Srivastava A; Arya P; Goel S; Kundu B; Mishra P; Fnu A
    PLoS One; 2015; 10(5):e0127011. PubMed ID: 25996685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid by Design: Intrinsic Regulation of Microbial Amyloid Assembly.
    Deshmukh M; Evans ML; Chapman MR
    J Mol Biol; 2018 Oct; 430(20):3631-3641. PubMed ID: 30017921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.